BG International Pharma Consulting

Genappe ·KBO/BCE: BE 0765.640.202

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-09-2025	61 d late	2025-00526922
31-12-2023	31-07-2024	30-08-2024	30 d late	2024-00406058
31-12-2022	31-07-2023	01-09-2023	32 d late	2023-00405384
31-12-2021	31-07-2022	31-08-2022	31 d late	2022-20373055

Metric	This company	Sector median	Position in the sector
Solvency	39.2%	56.2%	better than 34% of 2547 sector peers
Net result	€108k	€19k	better than 92% of 2549 sector peers
Equity	€139k	€43k	better than 82% of 2547 sector peers
Gross operating margin	€143k	€37k	better than 89% of 2546 sector peers
Total assets	€355k	€93k	better than 88% of 2549 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€355k
Fixed assets	21/28	€12k
Tangible fixed assets	22/27	€12k
Current assets	29/58	€343k
Amounts receivable within one year	40/41	€45k
Investments	50/53	€121k
Cash & bank	54/58	€177k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€355k
Equity	10/15	€139k
Contributions / capital	10/11	€5k
Reserves	13	€110k
Accumulated profits (losses)	14	€24k
Amounts payable	17/49	€216k
Amounts payable within one year	42/48	€216k
Trade debts payable within one year	44	€951
Income statement
Gross operating margin	9900	€143k
Operating result	9901	€140k
Financial income	75	€13
Financial charges	65	€304
Result before taxes	9903	€139k
Income taxes	67/77	€31k
Net result for the period	9904	€108k
Result to be appropriated	9905	€108k

Summary